BridgeBio to Participate in the J.P. Morgan Healthcare Conference

Company Overview - BridgeBio Pharma, Inc. is a biopharmaceutical company focused on discovering, creating, testing, and delivering transformative medicines for genetic diseases [3] - Founded in 2015, the company has a pipeline that includes programs from early science to advanced clinical trials [3] - The team consists of experienced drug discoverers, developers, and innovators dedicated to applying advances in genetic medicine [3] Upcoming Events - Co-founder and CEO Neil Kumar, Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at 7:30 am PT [1] - A live webcast of the investor webinar will be available on the BridgeBio website, with a replay accessible for 30 days post-event [2]